We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$13.4B
AUM Growth
+$5.98B
Cap. Flow
+$4.58B
Cap. Flow %
34.18%
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$51.4M
2
LOW icon
Lowe's Companies
LOW
+$45.3M
3
CVS icon
CVS Health
CVS
+$37.3M
4
LLY icon
Eli Lilly
LLY
+$32.7M
5
SO icon
Southern Company
SO
+$30.6M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Consumer Discretionary 11.59%
3 Healthcare 8.66%
4 Financials 6.8%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLMD icon
2776
Galmed Pharmaceuticals
GLMD
$3.94M
$65K ﹤0.01%
117
-16
-12% -$9.99K
NEXT icon
2777
NextDecade
NEXT
$1.85B
$65K ﹤0.01%
30,965
+2,457
+9% +$6.23K
FRTX
2778
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$65K ﹤0.01%
+1,862
New +$58.5K
IDXG
2779
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$65K ﹤0.01%
20,755
-4,410
-18% -$14.5K
IO
2780
DELISTED
ION Geophysical Corporation
IO
$65K ﹤0.01%
26,717
-52,674
-66% -$99K
BCLI
2781
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$64K ﹤0.01%
+950
New +$129K
RNET
2782
DELISTED
RigNet, Inc.
RNET
$64K ﹤0.01%
10,949
-96,493
-90% -$464K
TOPS icon
2783
TOP Ships
TOPS
$4.32M
$61K ﹤0.01%
210
-641
-75% -$181K
VTVT icon
2784
vTv Therapeutics
VTVT
$121M
$61K ﹤0.01%
821
-2
-0.2% -$153
ATRS
2785
DELISTED
Antares Pharma, Inc.
ATRS
$61K ﹤0.01%
15,339
-10,361
-40% -$33.5K
PSEC icon
2786
Prospect Capital
PSEC
$1.06B
$60K ﹤0.01%
+11,172
New +$58.8K
LNAI
2787
Lunai Bioworks
LNAI
$10.6M
$60K ﹤0.01%
256
-142
-36% -$35.9K
SMMT icon
2788
Summit Therapeutics
SMMT
$10.9B
$60K ﹤0.01%
+12,751
New +$54K
EQD.WS
2789
DELISTED
Equity Distribution Acquisition Corp. Warrants, each whole warrant exercisable for one share of Clas
EQD.WS
$60K ﹤0.01%
+33,333
New +$43.3K
SBBP
2790
DELISTED
Strongbridge Biopharma plc.
SBBP
$60K ﹤0.01%
24,493
+11,713
+92% +$28.2K
RTP.WS
2791
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
$60K ﹤0.01%
+18,750
New +$50.7K
SLS icon
2792
SELLAS Life Sciences
SLS
$2.23B
$59K ﹤0.01%
+10,081
New +$40.3K
BSIN
2793
Big Sky Industrial
BSIN
$67M
$59K ﹤0.01%
+15,958
New +$68.8K
DSX icon
2794
Diana Shipping
DSX
$280M
$58K ﹤0.01%
+43,119
New +$48.7K
CALA
2795
DELISTED
Calithera Biosciences, Inc
CALA
$58K ﹤0.01%
591
-944
-61% -$82.7K
APTO
2796
DELISTED
Aptose Biosciences, Inc.
APTO
$57K ﹤0.01%
+29
New +$68.1K
VRAY
2797
DELISTED
ViewRay, Inc.
VRAY
$56K ﹤0.01%
14,649
-58,009
-80% -$205K
BNBX
2798
DELISTED
BNB PLUS CORP
BNBX
$55K ﹤0.01%
1
CATX icon
2799
Perspective Therapeutics
CATX
$332M
$54K ﹤0.01%
12,014
+5,320
+79% +$23.5K
LXRX icon
2800
Lexicon Pharmaceuticals
LXRX
$1.02B
$53K ﹤0.01%
15,639
-152,515
-91% -$291K

Similar funds

Squarepoint's Q4 2020 Portfolio in Review

As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Squarepoint deployed $4.58B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.

  • Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
  • Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
  • Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
  • Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
  • Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
  • Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.